SLC1A3 and diabetes mellitus: In the present study, we found that the topical administration of SST in db/db mice or its addition to the culture medium of retinal explants prevented glial activation induced by diabetes and the downregulation of GLAST, thus reducing the extracellular concentration of glutamate and, consequently, ameliorating excitotoxicity and retinal neuronal death.